Header cover image

Australian (ASX) Pharma Industry Analysis

UpdatedMay 26, 2024
DataAggregated Company Financials
Companies30
  • 7D0.2%
  • 3M7.3%
  • 1Y56.2%
  • YTDn/a

The Pharma is pretty flat in the last 7 days, but Clarity Pharmaceuticals has stood out, gaining 5.1%. As for the the longer term, the industry is up 56% over the past 12 months. As for the next few years, earnings are expected to grow by 35% per annum.

Industry Valuation and Performance

Has the Australian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 26 May 2024AU$6.3bAU$1.2b-AU$374,923,684.0014.4x-16.7x5.1x
Tue, 23 Apr 2024AU$5.5bAU$1.2b-AU$374,923,684.0014.4x-14.7x4.5x
Thu, 21 Mar 2024AU$5.7bAU$1.2b-AU$374,923,684.0014.7x-15.2x4.7x
Sat, 17 Feb 2024AU$5.3bAU$892.3m-AU$534,729,129.0020.4x-9.9x5.9x
Mon, 15 Jan 2024AU$5.7bAU$896.3m-AU$589,604,392.0021.4x-9.7x6.4x
Wed, 13 Dec 2023AU$4.4bAU$896.3m-AU$589,604,392.0016.6x-7.4x4.9x
Fri, 10 Nov 2023AU$3.8bAU$893.0m-AU$595,020,018.0018.5x-6.4x4.3x
Sun, 08 Oct 2023AU$3.6bAU$900.3m-AU$587,952,018.0019x-6.1x4x
Tue, 05 Sep 2023AU$3.7bAU$904.4m-AU$608,775,601.0019.5x-6.1x4.1x
Thu, 03 Aug 2023AU$4.1bAU$999.0m-AU$624,794,303.0022.2x-6.5x4.1x
Sat, 01 Jul 2023AU$4.0bAU$999.0m-AU$624,794,303.0022.7x-6.3x4x
Mon, 29 May 2023AU$4.0bAU$993.2m-AU$640,306,659.0018x-6.2x4x
Wed, 26 Apr 2023AU$4.2bAU$993.2m-AU$641,969,868.0017.9x-6.6x4.2x
Fri, 24 Mar 2023AU$4.1bAU$995.9m-AU$648,651,745.0018.7x-6.3x4.1x
Sun, 19 Feb 2023AU$3.6bAU$980.5m-AU$583,404,566.0016.6x-6.2x3.7x
Tue, 17 Jan 2023AU$4.2bAU$948.3m-AU$544,428,006.0013.1x-7.6x4.4x
Thu, 15 Dec 2022AU$3.9bAU$948.3m-AU$544,428,006.0013.5x-7.2x4.1x
Sat, 12 Nov 2022AU$4.3bAU$948.3m-AU$544,428,005.0012.7x-8x4.6x
Mon, 10 Oct 2022AU$4.3bAU$946.2m-AU$548,400,005.0012.4x-7.9x4.6x
Wed, 07 Sep 2022AU$4.2bAU$943.2m-AU$537,548,829.0012.5x-7.7x4.4x
Fri, 05 Aug 2022AU$3.8bAU$819.9m-AU$339,669,589.0015.6x-11.3x4.7x
Sun, 03 Jul 2022AU$3.3bAU$818.2m-AU$353,932,589.0012.9x-9.3x4x
Tue, 31 May 2022AU$4.0bAU$818.2m-AU$353,932,589.0014.2x-11.2x4.9x
Thu, 28 Apr 2022AU$4.1bAU$800.9m-AU$348,637,558.0015.5x-11.6x5.1x
Sat, 26 Mar 2022AU$4.3bAU$799.2m-AU$341,805,125.0018x-12.7x5.4x
Mon, 21 Feb 2022AU$4.6bAU$749.8m-AU$463,466,291.0020.8x-10x6.2x
Wed, 19 Jan 2022AU$5.0bAU$758.4m-AU$450,516,414.0021.7x-11.1x6.6x
Fri, 17 Dec 2021AU$4.8bAU$758.4m-AU$450,516,414.0024.1x-10.6x6.3x
Sun, 14 Nov 2021AU$4.9bAU$758.4m-AU$447,307,205.0024x-11x6.5x
Tue, 12 Oct 2021AU$4.7bAU$753.7m-AU$446,965,453.0023.9x-10.5x6.2x
Thu, 09 Sep 2021AU$4.7bAU$753.9m-AU$445,060,581.0021.8x-10.6x6.3x
Sat, 07 Aug 2021AU$4.1bAU$752.8m-AU$442,004,016.0020.8x-9.3x5.5x
Price to Earnings Ratio

-9.9x


Total Market Cap: AU$4.5bTotal Earnings: -AU$452,149,714.00Total Revenue: AU$758.8mTotal Market Cap vs Earnings and Revenue0%0%0%
Australian Pharma Industry Price to Earnings3Y Average -9.3x202220232024
Current Industry PE
  • Investors are relatively neutral on the Australian Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 5.0x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Revenues for these companies have grown 17% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Comparison

How does Australian Pharma compare with similar industries?

AU Market-1.06%
Healthcare-0.59%
Pharma0.18%
Pharma0.18%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CU6 Clarity PharmaceuticalsAU$4.355.1%
+AU$65.3m
500.0%PS142.6x
BOT Botanix PharmaceuticalsAU$0.3011.1%
+AU$47.3m
244.8%PS1080.8x
LTP LTR PharmaAU$0.4525.4%
+AU$12.5m
n/an/a
VLS Vita Life SciencesAU$2.359.3%
+AU$11.1m
51.6%PE14.4x
ALA Arovella TherapeuticsAU$0.124.3%
+AU$5.3m
114.3%PS64x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

BOT

AU$0.30

Botanix Pharmaceuticals

7D

11.1%

1Y

244.8%

LTP

AU$0.45

LTR Pharma

7D

25.4%

1Y

n/a

MYX

AU$5.48

Mayne Pharma Group

7D

-14.0%

1Y

52.2%

CU6

AU$4.35

Clarity Pharmaceuticals

7D

5.1%

1Y

500.0%

RGT

AU$0.40

Argent BioPharma

7D

11.3%

1Y

-94.4%

VIT

AU$0.093

Vitura Health

7D

-15.5%

1Y

-70.5%

VLS

AU$2.35

Vita Life Sciences

7D

9.3%

1Y

51.6%

AGN

AU$0.70

Argenica Therapeutics

7D

5.2%

1Y

74.1%

ALA

AU$0.12

Arovella Therapeutics

7D

4.3%

1Y

114.3%

PER

AU$0.072

Percheron Therapeutics

7D

-4.0%

1Y

20.0%